TELO Telomir Pharmaceuticals, Inc.

Nasdaq telomirpharma.com


$ 1.36 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 07:14:54 EST
QQQ $ 620.04 $ 0.00 (0 %)
DIA $ 482.37 $ 0.00 (0 %)
SPY $ 682.34 $ 0.00 (0 %)
TLT $ 89.95 $ 0.00 (0 %)
GLD $ 389.50 $ 0.00 (0 %)
$ 1.35
$ 1.40
$ 1.35 x 1,514
$ 1.39 x 1
-- - --
$ 1.12 - $ 7.08
1,851,108
na
46.41M
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 02-04-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Telomir Pharmaceuticals (NASDAQ:TELO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate ...

Core News & Articles

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical biotechnology company ...

Core News & Articles

-SEC Filing

Core News & Articles

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology com...

Core News & Articles

Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expan...

Core News & Articles

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighti...

 telomir-pharmaceuticals-touts-promising-action-from-its-lead-breast-cancer-drug

Telomir Pharmaceuticals' stock rises as Telomir-1 shows strong lab results against aggressive triple-negative breast cancer...

Core News & Articles

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology com...

Core News & Articles

DAL: 6% | Delta Air Lines shares are trading higher after the company reported better-than-expected Q3 financial results and ra...

Core News & Articles

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells New f...

 stock-market-today-dow-jones-nasdaq-100-sp-500-futures-turn-greentrilogy-metals-amd-applovin-in-focus-updated

Editor’s Note: The future prices of benchmark tracking ETFs and lede were updated in the story.) US futures trimmed earlier ...

Core News & Articles

Findings show that Telomir-1 restores the body's natural tumor suppressor defenses by reversing abnormal DNA methylation of...

Core News & Articles

TMQ: 230% | Shares of mining companies that operate in Alaska are trading higher after President Trump signed an executive orde...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION